Tc 99m adrenomedullin

Drug Profile

Tc 99m adrenomedullin

Alternative Names: 99mTC-PulmoBind; DFH-12; PulmoBind

Latest Information Update: 26 Apr 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Montreal Heart Institute; Pulmo BioTech
  • Class Heavy metals; Peptide hormones; Radiopharmaceutical diagnostics; Transition elements
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Pulmonary embolism; Pulmonary hypertension

Most Recent Events

  • 09 Jul 2008 PulmoScience completes preclinical biodistribution studies in the US
  • 16 May 2008 Preclinical trials in Pulmonary embolism in USA (IV)
  • 16 May 2008 Preclinical trials in Pulmonary hypertension in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top